) has been revised to $20.14 / share. This is a decrease of 26.34% from the prior estimate of $27.34 dated April 12, 2026. The price target is an average of many targets provided by analysts. The ...

While the initial complaint focused primarily on the failure to timely file financial reports and deficient internal controls, the expanded complaint alleges that throughout the Class Period, Kyndryl ...

At spin-off, each Kyndryl share was worth 5% of an IBM share and the company was a loss-making business in a declining industry that few wanted to own. Although Kyndryl appeared to be an unattractive ...